TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 Share Price Today: Live Updates & Key Insights
TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 share price today is $0.035999, up -2.44%. The stock opened at $0.0369 against the previous close of $0.0369, with an intraday high of $0.0369 and low of $0.0369.
TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 Share Price Chart
TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029
TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 Share Price Performance
TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 Institutional Holdings
TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 Market Status
TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 Fundamentals
Market Cap 0.00 M
PB Ratio 0.0
PE Ratio 0.0
Enterprise Value 0.00 M
Total Assets 3.46 M
Volume 27067
TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 Company Financials
About TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 & investment objective
Company Information Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920 which is in preclinical trial for treating cervical cancer; TVGN 960 which is in preclinical trial for treating oropharyngeal cancer; TVGN 601 which is in preclinical trial for treating multiple sclerosis; TVGN 930 which is in preclinical trial for treating Epstein-Barr virus associated lymphomas; and TVGN 116 a product candidate targeted at hepatitis B and is in preclinical trial. Tevogen Bio Holdings Inc. was formerly known as Tevogen Bio Inc. and changed its name to Tevogen Bio Holdings Inc. in February 2024. The company was founded in 2020 and is headquartered in Warren, New Jersey.
Organisation
Employees 18
Industry
CEO Dr. Ryan H. Saadi M.D., M.P.H.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 FAQs
What is the share price of TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 today?
The current share price of TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 is $0.035999.
Can I buy TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 shares in India?
Yes, Indian investors can buy TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 shares by opening an international trading and demat account with Motilal Oswal.
How to buy TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 shares in India?
You can easily invest in TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029.
Can I buy fractional shares of TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029?
TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 has a market cap of $0.00 M.
In which sector does TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 belong?
TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 operates in the sector.
What documents are required to invest in TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 stocks?
To invest, you typically need:
What is the PE and PB ratio of TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029?
The PE ratio of TEVOGEN BIO HOLDINGS EQUITY WARRANT EXP 14 FEBRUARY 2029 is N/A and the PB ratio is N/A.